Fri Aug 4 16:55:14 2006
Robust hepatitis C virus infection in vitro
Zhong J, Gastaminza P, Cheng GF, et al.
PNAS 102 (26): 9294-9299 JUN 28 2005
and citing papers
stopwords, and 2-character and smaller words are excluded, Word count: 611, All words count: 910
Grand TLCS: 121, Grand TGCS: 212| View: Overview | Sorted by LCS. |
Page 2 of 2: [ 1 2 ]
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 201 | INDEPENDENT | 1 | 0 | 0
|
| 202 | INDUCED | 2 | 0 | 0
|
| 203 | INHIBIT | 1 | 0 | 0
|
| 204 | INHIBITION | 2 | 0 | 1
|
| 205 | INHIBITOR | 4 | 0 | 1
|
| 206 | INHIBITORS | 2 | 0 | 0
|
| 207 | INNATE | 2 | 0 | 2
|
| 208 | INSERTION | 1 | 0 | 0
|
| 209 | INSIGHTS | 1 | 0 | 0
|
| 210 | INTERACTION | 2 | 0 | 0
|
| 211 | INTERFERENCE-MEDIATED | 1 | 0 | 0
|
| 212 | INTERFERING | 1 | 0 | 2
|
| 213 | INTERFERON-SENSITIVE | 1 | 0 | 1
|
| 214 | INTERFERONS | 1 | 0 | 2
|
| 215 | INTERGENOTYPIC | 1 | 0 | 0
|
| 216 | INTERNAL | 1 | 0 | 0
|
| 217 | INTRAGENOTYPIC | 1 | 0 | 0
|
| 218 | LIPOPROTEINS | 2 | 0 | 0
|
| 219 | LIVER | 2 | 0 | 0
|
| 220 | LUCIFERASE | 2 | 0 | 0
|
| 221 | MATURATION | 1 | 0 | 0
|
| 222 | MEASUREMENT | 1 | 0 | 0
|
| 223 | MECHANISM-BASED | 1 | 0 | 0
|
| 224 | MECHANISMS | 1 | 0 | 0
|
| 225 | MEDIATED | 1 | 0 | 0
|
| 226 | MEMBRANES | 1 | 0 | 0
|
| 227 | MENACE | 1 | 0 | 0
|
| 228 | MILESTONE | 1 | 0 | 0
|
| 229 | MODELING | 1 | 0 | 0
|
| 230 | MODELS | 1 | 0 | 1
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 231 | MODULATES | 1 | 0 | 0
|
| 232 | MONOCLONAL | 1 | 0 | 0
|
| 233 | MORPHOGENESIS | 1 | 0 | 0
|
| 234 | MOVE | 1 | 0 | 0
|
| 235 | MUTAGENESIS | 1 | 0 | 0
|
| 236 | NATURAL | 1 | 0 | 0
|
| 237 | NEUTRALIZING | 1 | 0 | 0
|
| 238 | NEW | 1 | 0 | 0
|
| 239 | NON-IMMUNOSUPPRESSIVE | 1 | 0 | 0
|
| 240 | NON-STRUCTURAL | 1 | 0 | 0
|
| 241 | NONSTRUCTURAL | 1 | 0 | 0
|
| 242 | NOVEL | 2 | 0 | 1
|
| 243 | NS34A | 1 | 0 | 0
|
| 244 | NS5B | 1 | 0 | 0
|
| 245 | NS5B-NUCLEOLIN | 1 | 0 | 0
|
| 246 | NUMBER | 1 | 0 | 0
|
| 247 | OLIGONUCLEOTIDE-BASED | 1 | 0 | 0
|
| 248 | OPTIONS | 1 | 0 | 0
|
| 249 | OXLDL | 1 | 0 | 0
|
| 250 | PARALLEL | 1 | 0 | 0
|
| 251 | PARTICLES | 2 | 0 | 0
|
| 252 | PEPTIDE | 1 | 0 | 0
|
| 253 | PESTIVIRUS | 1 | 0 | 1
|
| 254 | PHANTOM | 1 | 0 | 0
|
| 255 | POLYMERASE | 2 | 0 | 1
|
| 256 | POLYPROTEIN | 1 | 0 | 0
|
| 257 | POTENT | 2 | 0 | 0
|
| 258 | POTENTIAL | 2 | 0 | 0
|
| 259 | PRACTICE | 1 | 0 | 1
|
| 260 | PREVENTION | 1 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 261 | PROFILES | 1 | 0 | 0
|
| 262 | PROPERTIES | 1 | 0 | 0
|
| 263 | PROTEASE | 2 | 0 | 0
|
| 264 | PROTEASE-DEPENDENT | 1 | 0 | 0
|
| 265 | PSEUDOPARTICLE | 1 | 0 | 0
|
| 266 | REARRANGEMENT | 1 | 0 | 0
|
| 267 | RECENT | 1 | 0 | 1
|
| 268 | RECEPTOR | 2 | 0 | 0
|
| 269 | RECEPTORS | 2 | 0 | 0
|
| 270 | REGIONS | 1 | 0 | 0
|
| 271 | REPLICONS | 1 | 0 | 0
|
| 272 | REPORTER | 2 | 0 | 0
|
| 273 | RESEARCH | 2 | 0 | 0
|
| 274 | RESPONSES | 2 | 0 | 0
|
| 275 | RIGING | 1 | 0 | 0
|
| 276 | RNA | 8 | 0 | 2
|
| 277 | RNA-DEPENDENT | 1 | 0 | 1
|
| 278 | ROLE | 1 | 0 | 0
|
| 279 | SAR | 1 | 0 | 0
|
| 280 | SCAVENGER | 2 | 0 | 0
|
| 281 | SCH | 1 | 0 | 0
|
| 282 | SECRETION | 1 | 0 | 0
|
| 283 | SELECTIVE | 1 | 0 | 1
|
| 284 | SHORT | 1 | 0 | 0
|
| 285 | SIGNAL | 1 | 0 | 0
|
| 286 | SIGNALING | 1 | 0 | 0
|
| 287 | SIGNALS | 1 | 0 | 0
|
| 288 | SIMULTANEOUS | 1 | 0 | 0
|
| 289 | SINUSOIDAL | 1 | 0 | 0
|
| 290 | SR-BI | 1 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 291 | STAGES | 1 | 0 | 0
|
| 292 | STATINS | 1 | 0 | 0
|
| 293 | STEPS | 1 | 0 | 0
|
| 294 | STIMULATING | 1 | 0 | 0
|
| 295 | STRATEGIES | 1 | 0 | 0
|
| 296 | STRUCTURE | 1 | 0 | 0
|
| 297 | SUBGENOMIC | 3 | 0 | 0
|
| 298 | SUPPRESSES | 1 | 0 | 0
|
| 299 | SUSTAINED | 1 | 0 | 1
|
| 300 | TARGET | 1 | 0 | 0
|
| 301 | TARGETING | 1 | 0 | 0
|
| 302 | TARGETS | 2 | 0 | 1
|
| 303 | TETRASPANIN | 1 | 0 | 0
|
| 304 | THERAPY | 3 | 0 | 0
|
| 305 | THIENYL | 1 | 0 | 0
|
| 306 | THREE-DIMENSIONAL | 1 | 0 | 0
|
| 307 | TOLL-LIKE | 1 | 0 | 0
|
| 308 | TRACT | 1 | 0 | 0
|
| 309 | TRANSIENT-REPLICATION | 1 | 0 | 0
|
| 310 | TRANSLATION | 1 | 0 | 1
|
| 311 | TRAP | 1 | 0 | 0
|
| 312 | TRIGGER | 1 | 0 | 0
|
| 313 | TROJAN | 1 | 0 | 0
|
| 314 | TWO | 1 | 0 | 0
|
| 315 | TWO-AND | 1 | 0 | 0
|
| 316 | USING | 2 | 0 | 0
|
| 317 | VECTORS | 1 | 0 | 0
|
| 318 | VIABLE | 1 | 0 | 0
|
| 319 | VIROLOGIC | 1 | 0 | 1
|
| 320 | VIROLOGY | 1 | 0 | 0
|
| # | Word | Pubs | TLCS | TGCS
|
|---|
| 321 | VIRUS-INFECTED | 1 | 0 | 0
|
| 322 | VIRUS-LIKE | 1 | 0 | 0
|
| 323 | VIRUS-NEUTRALIZING | 1 | 0 | 0
|
| 324 | VIRUSES | 1 | 0 | 0
|
Page 2 of 2: [ 1 2 ]